recurrent head and neck squamous cell carcinoma Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 2 (3)

Interventional (3)

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (1)
Merck Sharp & Dohme Corp. (1)
Wake Forest University Health Sciences (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadimmunodeficiency

I am/have/hadmetastatic squamous cell carcinoma

I am/have/hadHIV Infection

I am/have/hadpulmonary disease

I am/have/hadautoimmune disease

I am/have/hadct scan

I am/have/hadneutrophil count

I am/have/hadplatelet count

I am/have/haddiabetes

I am/have/hadkidney function tests

I am/have/hadleptomeningeal metastases

I am/have/hadliver metastasis

I am/have/hadmetastatic head and neck squamous cell cancer

I am/have/hadcancer of the head

I am/have/hadautoimmune thyroiditis

I am/have/hadmetastatic head and neck squamous cell carcinoma

I am/have/hadsolid tumour

I am/have/hadmeasurable disease

I am/have/hadmajor surgery

I am/have/hadneuropathy

added new label for I am/have/had

I am looking for

I am looking foredta

I am looking forcarboplatin

I am looking foradjuvant

I am looking forcisplatin

I am looking forpd-1 inhibitor

I am looking forhepatitis b

I am looking forcetuximab

I am looking formonoclonal antibodies

I am looking fornivolumab

I am looking formelanoma

I am looking forpembrolizumab

I am looking forcorticosteroids

I am looking forpaclitaxel

I am looking forimmunosuppressive agents

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Study of Intratumoral (IT) MK-1454 in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

The purpose of this study is to assess the efficacy and safety of intratumoral (IT) MK-1454 in PLUS pembrolizumab (MK-3475) compared to pembrolizumab alone as a first line treatment of adults with metastatic or unresectable, recurrent head and neck squamous cell carcinoma (HNSCC). The primary study hypotheses are that IT …

solid tumour

immunodeficiency

measurable disease

HIV Infection

recurrent head and neck squamous cell carcinoma

0 views
19 Feb, 2024

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma is palliative and usually platinum based, and the patients often present with poor physical condition. Consequently, many of them are not able to withstand a platinum-based chemotherapy. The addition of taxanes to the armamentarium of drugs improve the outcome …

immunodeficiency

metastatic squamous cell carcinoma

pulmonary disease

autoimmune disease

ct scan

0 views
19 Feb, 2024

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

This is a Phase II treatment, non-randomized, open label clinical trial to study the efficacy of the Cetuximab when administered as single agent in recurrent/ metastatic head and neck squamous cell carcinoma after the failure or intolerance of immuno-oncology or immuno-oncology combined with chemotherapy.

metastatic head and neck squamous cell carcinoma

measurable disease

recurrent head and neck squamous cell carcinoma

metastatic squamous cell carcinoma

pd-1 inhibitor

0 views
19 Feb, 2024